115 related articles for article (PubMed ID: 28533643)
21. Detection by (18)F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheek.
Joshi P; Kulkarni MJ; Abhyankar A; Shet T; Basu S
Hell J Nucl Med; 2011; 14(3):307-8. PubMed ID: 22087455
[TBL] [Abstract][Full Text] [Related]
22.
Ulaner GA; Juarez J; Riedl CC; Goldman DA
J Nucl Med; 2019 Apr; 60(4):472-477. PubMed ID: 30237211
[No Abstract] [Full Text] [Related]
23. Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Jackson T; Mosci C; von Eyben R; Mittra E; Ganjoo K; Biswal S; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Sep; 40(9):720-4. PubMed ID: 26053718
[TBL] [Abstract][Full Text] [Related]
24. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
[TBL] [Abstract][Full Text] [Related]
25. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H
Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
[TBL] [Abstract][Full Text] [Related]
26. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
[TBL] [Abstract][Full Text] [Related]
27. 18-F fluorodeoxyglucose positron emission tomography indicating unsuspected infections in two patients with dermatomyositis.
Bachmeyer C; Kerrou K; Chosidow O; Frances C; Montravers F
Clin Exp Dermatol; 2009 Dec; 34(8):e769-71. PubMed ID: 20055842
[TBL] [Abstract][Full Text] [Related]
28. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma.
Povoski SP; Hall NC; Martin EW; Walker MJ
World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
[TBL] [Abstract][Full Text] [Related]
30. The Role of Quantitative and Semi-quantitative [
Yildiz H; D'abadie P; Gheysens O
Front Med (Lausanne); 2022; 9():883727. PubMed ID: 35492313
[TBL] [Abstract][Full Text] [Related]
31.
Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
[TBL] [Abstract][Full Text] [Related]
32.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
33. Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.
Nanni C; Rubello D; Castellucci P; Farsad M; Franchi R; Toso S; Barile C; Rampin L; Nibale O; Fanti S
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):589-92. PubMed ID: 15726356
[TBL] [Abstract][Full Text] [Related]
34. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of F-18 FDG PET/CT as one-stop-shop imaging modality for diagnosis of occult primary and estimation of disease burden in patients with intraocular masses.
Manohar K; Mittal BR; Kulkarni P; Singh N; Bhattacharya A; Gupta A
Clin Nucl Med; 2012 Feb; 37(2):200-3. PubMed ID: 22228354
[TBL] [Abstract][Full Text] [Related]
36. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
Mahajan S; Barker CA; Singh B; Pandit-Taskar N
Nucl Med Commun; 2019 Jul; 40(7):744-751. PubMed ID: 31095044
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
39. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
40. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
